PI
MGRX icon

PEAK6 Investments’s Mangoceuticals MGRX Stock Holding History

PEAK6 Investments’s Portfolio MGRX Stock Details MGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$20.8K Sell
5,884
-6
-0.1% -$28 ﹤0.01% 3197
2024
Q2 		$26.9K Buy
+5,890
New +$27.3K ﹤0.01% 3239

Other funds holding MGRX

ACA
Ackerman Capital Advisors Dallas, Texas $488M AUM 14.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
SG
StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return

PEAK6 Investments's MGRX Position: Q3 2024 in Review

PEAK6 Investments reduced its Mangoceuticals (MGRX) stake by 0.1% in Q3 2024, selling an estimated $28 and leaving 5,884 shares worth $20.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3197.

PEAK6 Investments first reported a position in MGRX in Q2 2024 and has held it in 2 quarters since. The position peaked at $26.9K in Q2 2024. 13 funds tracked by Wall St. Rank hold MGRX as of Q3 2024.

  • PEAK6 Investments held 5,884 shares of Mangoceuticals worth $20.8K as of Q3 2024.
  • PEAK6 Investments sold 6 Mangoceuticals shares in Q3 2024, an estimated $28.
  • Mangoceuticals made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #3197 holding.
  • PEAK6 Investments first reported a position in Mangoceuticals in Q2 2024 and has held it in 2 quarters since.
  • PEAK6 Investments's Mangoceuticals position peaked at $26.9K in Q2 2024.
  • 13 funds tracked by Wall St. Rank held Mangoceuticals as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.